Atossa Genetics (ATOS) Tops Q2 EPS by 1c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD66 at RBC Capital
• RBC Capital Starts Innio NV (INIO) at Sector Perform
• Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal